Bavarian Nordic reports Phase III data for smallpox vaccine

Jynneos vaccine has been assessed in a comprehensive development programme of 22 clinical trials. Credit: Bavarian Nordic.



  • Bavarian Nordic reports Phase III data for smallpox vaccine Jynneos